Rottenstein Law Group LLP Notes Rise in Number of Reported Alleged Injuries Prompting Xarelto Lawsuits
In 2013, the U.S. FDA received several hundred adverse event reports submitted by individuals who claimed to have a serious adverse side effect while taking Xarelto (rivaroxaban) (http://www.xareltoinjuryfirm.com), as compared to a lower number for Pradaxa (dabigatran).* Data show that the number of persons being prescribed these blood thinning drugs is estimated at about 4 million for the year, with Xarelto prescriptions outnumbering Pradaxa prescriptions by two-to-one.* Anticoagulants (or “blood thinners”) are considered high-risk prescription drugs because they can cause...
View full press release